^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CART-PSMA- TGFβRDN cells

    i
    Associations
    News
    Trials
    Company:
    Gilead
    Drug class:
    PSMA-targeted CAR-T immunotherapy, TGF-βRDN-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials